Migraine Drugs Market Size

Migraine drugs Market Size

Migraine Drugs Market size was valued at USD 6.2 billion in 2023 growing at a CAGR of 6.7% from 2024 and 2032, driven by factors such as the rising prevalence of migraine. This can be attributed to factors such as stress, lifestyle changes, and dietary habits.

To get key market trends

  Download Free Sample

For instance, as per the report published by World Health Organization, it has been reported that globally, headache disorders affect approximately 40% of the population, or 3.1 billion people in 2021, and are more common in females compared to males. Migraine is among the top three most common neurological conditions for most age groups.
 

Similarly, as per an article published in National Library of Medicine, it has been reported that India and China collectively accounted for over 25% of global migraine cases, while also contributing substantially to tension-type headache (TTH) prevalence. Thus, the rapid increase in the prevalence of migraine globally is the major factor that is expanding the treatment landscape for migraine and is anticipated to foster the growth of the market.
 

Migraine drugs are medications specifically designed to treat or prevent migraines, a type of headache characterized by intense, throbbing pain, often accompanied by nausea, vomiting, and sensitivity to light and sound. The drugs used in migraine can be categorized into two main groups, pain-relieving medication and preventive medication. Further, a migraine headache is caused by abnormal activities of brain observed or measured through brain monitoring devices.